Recombinant SARS-CoV-2 lacking initiating and internal methionine codons within ORF10 is attenuated in vivo (2023)

First Author: Gu S

Attributed to: The production and application of SARS-CoV-2 reverse genetic systems to facilitate vaccine development and biosafe drug discovery platforms. funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.08.04.551973

Publication URI: http://dx.doi.org/10.1101/2023.08.04.551973

Type: Preprint